Welcome to our dedicated page for Smith & Nephew SEC filings (Ticker: SNN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Smith & Nephew plc (SNN) regulatory disclosures filed with the U.S. Securities and Exchange Commission, primarily through Form 6-K current reports for foreign private issuers. These filings give investors structured insight into the company’s capital structure, strategy, acquisitions and transactions by senior management.
Smith & Nephew uses Form 6-K to report a range of information, including announcements about its RISE strategy and related 2028 financial targets for revenue growth, trading profit, free cash flow and post-tax return on invested capital. Other 6-Ks detail portfolio rationalisation plans, guidance for upcoming financial years, and information on Capital Markets Day events where management presents strategic and product updates.
Filings also include voting rights and capital disclosures, setting out the total issued share capital, treasury shares and the number of voting rights that shareholders should use when assessing notification thresholds under applicable transparency rules. Separate TR-1 notifications, reproduced within 6-Ks, report major holdings changes by institutional investors such as BlackRock, Inc., including the percentage of voting rights attached to shares and through financial instruments.
Additional 6-K reports provide Market Abuse Regulation-compliant notifications of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. These cover purchases of ordinary shares and American Depositary Shares, participation in dividend reinvestment and employee stock purchase plans, and vesting of restricted share awards, giving a view of insider dealing activity around SNN securities.
Investors can also find transaction-related disclosures, such as the acquisition of Integrity Orthopaedics and its Tendon Seam™ rotator cuff repair technology, including headline deal terms, strategic rationale within the Sports Medicine portfolio and comments from management. By combining real-time EDGAR updates with AI-powered summaries, this page helps users navigate Smith & Nephew’s 6-Ks, understand the implications of voting rights and insider transactions, and quickly grasp the strategic content of narrative announcements without reading every paragraph in full.
Smith & Nephew plc reported a notification of share purchases by a Non-Executive Director. On 20 August 2025 Sybella Stanley purchased 1,520 ordinary shares of US$0.20 each. The filing states the purchase was made in line with the company's Remuneration Policy to pay part of Non-Executive Directors' fees in shares, and that the shares were acquired net of tax and expenses. The report is a standard Section 16-style disclosure of transactions by persons discharging managerial responsibilities.
Smith & Nephew plc reported the partial vesting of awards under its Restricted Share Plan 2024. Awards granted on 16 August 2024 vest in three equal tranches on each anniversary, subject to a judgement by the Remuneration Committee. On 19 August 2025 the company received notifications that a Director had 43,839 ordinary shares vesting, of which 18,007 were sold to cover tax and 25,832 were retained. A Non-Executive Director had 2,800 shares vest. The notice discloses these transactions following the vesting event.
Smith & Nephew reported the partial vesting of conditional share awards granted under the Global Share Plan 2020. One tranche vested on 12 August 2025 from awards originally granted on 11 August 2023, which follow a three-year vesting schedule where one third vests each year.
For the disclosed individual, Rohit Kashyap (President, Advanced Wound Management and Global), 23,201 ordinary shares vested at a reported price of £13.571365. Of these, 5,670 shares were sold to cover taxation and 17,531 were retained. The transactions were executed on the London Stock Exchange for ISIN GB0009223206.
Smith & Nephew plc (SNN) has filed a Form 6-K dated 7 Aug 2025 disclosing an insider transaction under the UK Market Abuse Regulation.
- Executive: Elga Lohler, Chief HR Officer (classified as a PDMR).
- Action: Sale of ordinary shares.
- Volume: 12,559.65422 shares.
- Price: £13.407957 per share.
- Gross proceeds: ≈ £168 k.
- Venue: London Stock Exchange (XLON).
- ISIN: GB0009223206.
No financial results, guidance changes or strategic announcements accompany the filing. The disclosure appears administrative, fulfilling regulatory obligations, but investors may monitor future insider activity for sentiment cues.